RECORD4 Trial of Rivaroxaban, Published in 2009, Still Turning Heads - TCTMD
Todd Neale |
Technology |
TCTMD |
01-19-2023 |
26
Concerns around the integrity of data from the RECORD4 trial of rivaroxaban (Xarelto; Bayer/Janssen), which were identified by the US Food and Drug Administration more than a decade ago, have been reâ
PKR (Rs)
USD ($)
EURO (€)
